Lexaria Bioscience (LEXX) Cash & Equivalents (2010 - 2026)
Lexaria Bioscience's Cash & Equivalents was $3.48 million in fiscal Q3 2026 (quarter ended May 31, 2026), down 24.3% from $4.59 million a year earlier and down 32.2% from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Aug 31, 2025), Cash & Equivalents at Lexaria Bioscience came in at $1.8 million, down 72.3% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of 6.9% (FY2020 to FY2025).
- In earlier fiscal years, Cash & Equivalents was $6.5 million in FY2024 (+380.7%), $1.35 million in FY2023 (-76.7%), $5.81 million in FY2022 (-46.8%) and $10.92 million in FY2021 (+743.9%).
- Quarterly Cash & Equivalents has moved between $1.35 million (fiscal Q4 2023) and $10.92 million (fiscal Q4 2021) over five years.
- Compared with a year earlier, Cash & Equivalents has declined for five straight quarters, with growth averaging 65.2% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was fiscal Q4 2021 (growth of 743.9%); the worst was fiscal Q4 2023 (a decline of 76.7%).
- Per Business Quant data, LEXX's Cash & Equivalents in the three fiscal quarters before Q3 2026 was $5.13 million (Q2 2026), $4.28 million (Q1 2026) and $1.8 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Lexaria Bioscience | 3.04 Mn | -12.61 Mn | - | 3.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 3.48 Mn |
| Feb 28, 2026 | 5.13 Mn |
| Nov 30, 2025 | 4.28 Mn |
| Aug 31, 2025 | 1.80 Mn |
| May 31, 2025 | 4.59 Mn |
| Feb 28, 2025 | 6.47 Mn |
| Nov 30, 2024 | 8.08 Mn |
| Aug 31, 2024 | 6.50 Mn |
| May 31, 2024 | 8.46 Mn |
| Feb 29, 2024 | 4.71 Mn |
| Nov 30, 2023 | 1.95 Mn |
| Aug 31, 2023 | 1.35 Mn |
| May 31, 2023 | 3.16 Mn |
| Feb 28, 2023 | 3.27 Mn |
| Nov 30, 2022 | 4.53 Mn |
| Aug 31, 2022 | 5.81 Mn |
| May 31, 2022 | 7.05 Mn |
| Feb 28, 2022 | 8.36 Mn |
| Nov 30, 2021 | 9.68 Mn |
| Aug 31, 2021 | 10.92 Mn |
API Access
Lexaria Bioscience Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();